These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22065579)

  • 1. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
    Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
    J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
    Miralem T; Lerner-Marmarosh N; Gibbs PE; Tudor C; Hagen FK; Maines MD
    J Biol Chem; 2012 Jul; 287(29):24698-712. PubMed ID: 22584576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
    Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
    FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
    Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
    J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
    Gibbs PE; Miralem T; Maines MD
    FASEB J; 2010 Sep; 24(9):3239-54. PubMed ID: 20410444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
    Miralem T; Gibbs PE; Revert F; Saus J; Maines MD
    J Biol Chem; 2010 Apr; 285(17):12551-8. PubMed ID: 20177069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.
    Gibbs PE; Maines MD
    Int J Cancer; 2007 Dec; 121(11):2567-74. PubMed ID: 17683071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
    Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
    J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.
    Gibbs PE; Tudor C; Maines MD
    Front Pharmacol; 2012; 3():31. PubMed ID: 22419908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1.
    Leppänen T; Korhonen R; Laavola M; Nieminen R; Tuominen RK; Moilanen E
    PLoS One; 2013; 8(1):e52741. PubMed ID: 23326354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.
    Gibbs PE; Lerner-Marmarosh N; Poulin A; Farah E; Maines MD
    FASEB J; 2014 Jun; 28(6):2478-91. PubMed ID: 24568842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.
    Kapitulnik J; Maines MD
    Trends Pharmacol Sci; 2009 Mar; 30(3):129-37. PubMed ID: 19217170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro.
    Bhatt KH; Pandey RK; Dahiya Y; Sodhi A
    Mol Immunol; 2010 Jan; 47(4):861-70. PubMed ID: 19931912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
    Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
    Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-Propyl gallate suppresses lipopolysaccharide-induced inducible nitric oxide synthase activation through protein kinase Cδ-mediated up-regulation of heme oxygenase-1 in RAW264.7 macrophages.
    Jeon W; Park SJ; Kim BC
    Eur J Pharmacol; 2017 Apr; 801():86-94. PubMed ID: 28286125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast).
    Platten M; Eitel K; Wischhusen J; Dichgans J; Weller M
    Biochem Pharmacol; 2003 Oct; 66(7):1263-70. PubMed ID: 14505805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.